Lycopene againsts the polystyrene microplastics-induced neurotoxicity via modulation of mTOR/Beclin-1 activities in adult male Wistar rats
Polystyrene microplastics (PS-MPs) pose a significant threat to aquatic ecosystems, causing neuronal toxicity in aquatic species, and Lycopene (LYC), a neuroprotective substance, could potentially mitigate this issue. This study examined the neurotherapeutic benefit of lycopene on the neurochemical...
Gespeichert in:
Veröffentlicht in: | Clinical Traditional Medicine and Pharmacology 2024-12, Vol.5 (4), p.200180, Article 200180 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Polystyrene microplastics (PS-MPs) pose a significant threat to aquatic ecosystems, causing neuronal toxicity in aquatic species, and Lycopene (LYC), a neuroprotective substance, could potentially mitigate this issue.
This study examined the neurotherapeutic benefit of lycopene on the neurochemical status of rats affected by PS-MPs.
Twenty Wistar rats were divided into four groups of five rats each: a vehicle group, a PS-MPs treatment group, a PS-MPs + LYC co-treatment group, and an LYC supplementation group. The experiment lasted 56 days, and all substances were administered orally. Neuronal toxicity was evaluated using oxidative stress/neurochemical biomarkers. Lipid peroxidation (LPO), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) were measured as indicators of oxidative stress. Nitric Oxide (NO), gamma-aminobutyric acid (GABA), hydroxyl radical (•OH), ammonia, and glutamate levels were assessed to evaluate neurotransmitter balance. Cathepsin marker enzyme activity was also measured to assess lysosomal function.
PS-MPs-treated animals showed increased LPO, NO, •OH, Bcl-2 interacting protein 1 (Beclin-1), ammonia, glutamate, and reduced GABA, Mammalian targets of rapamycin (mTOR), and antioxidant activity in their cerebral cortex. The combination of PS-MPs and Lycopene treatment improved GABA, cathepsin marker enzyme activity, and brain structure, restoring normal neuronal bodies, oval nuclei, and cerebral cortex. Lycopene ameliorated oxidative stress deficits, decreased LPO, NO, •OH, ammonia, and glutamate levels, and restored antioxidant enzyme activity.
In conclusion, the findings suggest a potential link between PS-MPs and cognitive dysfunction through neurochemical alterations, while the administration of lycopene mitigated the neurochemical changes brought on by PS-MPs.
[Display omitted] |
---|---|
ISSN: | 2097-3829 |
DOI: | 10.1016/j.ctmp.2024.200180 |